How to Build an Evidence Base for Digital Health Interventions in LMICs

Evidence base digital health interventions LMICs work is finally moving past the old pilot-era script. A decade ago, many programs were still satisfied with screenshots, uptake graphs, and a closing slide about "promising early signals." That is not enough now. Ministries want evidence they can budget around. Donors want evidence they can defend. Implementing partners want proof that a tool still works when the network drops, staff turnover hits, and the project leaves the capital city.

"Implementation outcomes" such as acceptability, adoption, feasibility, fidelity, penetration, and sustainability are distinct from clinical outcomes and often determine whether an intervention survives in practice. — Enola Proctor and colleagues, Washington University in St. Louis, 2011

How to build an evidence base for digital health interventions in LMICs

The first mistake is treating evidence as a single study. In practice, a credible evidence base is layered. The World Health Organization's 2016 guide Monitoring and Evaluating Digital Health Interventions, developed with Johns Hopkins University and the UN Foundation, was built around that idea. Programs need routine monitoring, implementation research, outcome evaluation, and reporting discipline. One data source rarely tells the whole story.

In low- and middle-income countries, that layered approach matters even more because program conditions are messy in ways that are easy to understate. Connectivity can be unstable. Device replacement can lag. Supervisory structures vary by district. A tool may work well in one province and stall in another for reasons that have nothing to do with the interface.

So the real job is not to prove that digital health is good. That question is too vague to be useful. The better question is narrower: what kind of evidence makes a ministry, donor, or delivery partner trust that a specific intervention is worth scaling?

A strong evidence base usually includes:

• Monitoring data that shows whether the intervention is actually being used
• Implementation evidence that explains adoption, fidelity, and barriers
• Service or health outcomes that show whether workflows or care improved
• Economic evidence that shows whether the intervention earns its keep
• Equity evidence that shows who benefits and who gets left out

Comparison table: what an evidence base should contain

Evidence layer	What it answers	Typical metrics	What goes wrong if it is missing
Monitoring	Is the intervention functioning in the field?	active users, sync success, completion rates, uptime, referral logs	Teams confuse rollout with routine use
Implementation research	Why is adoption strong or weak?	acceptability, feasibility, fidelity, training completion, supervisor response	Leaders do not know whether failure came from the tool or the rollout
Outcome evaluation	Did services or health outcomes improve?	screening coverage, referral completion, wait times, case detection, adherence	Programs make scale decisions on activity metrics alone
Economic evaluation	Is this worth funding over time?	cost per screen, cost per referral completed, staff time saved, incremental cost-effectiveness	Donors fund pilots that domestic budgets cannot absorb
Equity analysis	Who benefits, and who does not?	uptake by geography, language, sex, disability, device access, connectivity profile	Digital tools widen gaps instead of closing them

I keep coming back to one uncomfortable truth here: plenty of digital health programs generate evidence, but much less often the kind of evidence a public system can act on.

Start with implementation science, not just outcome claims

This is where global health teams sometimes get tripped up. They chase downstream outcomes before they have shown that the intervention can be delivered consistently. Proctor's 2011 implementation outcomes framework is still useful because it names the operational questions people usually skip. Was the tool acceptable to users? Did sites adopt it? Did staff use it as intended? Did it stay in use after launch?

Those are not secondary questions. In many LMIC deployments, they are the main event.

A 2024 review by Lynda Odoh and Obehi Aimiosior looked at implementation science strategies applied to patient-focused digital health interventions in LMICs. Their review covered studies from eight countries and found that interventions using more deliberate implementation strategies tended to achieve better adoption and utilization. That sounds dry, but the implication is practical: better evidence does not appear by accident. It usually follows better implementation design.

The RE-AIM framework is helpful here too. Danielle D'Lima at University College London, with Tayana Soukup and Louise Hull at King's College London, found in their 2021 updated review that reach was commonly reported while maintenance was less consistently covered. In other words, digital health teams often get good at saying who touched the tool and much worse at showing whether the intervention held up.

That pattern should shape study design from the start.

Useful implementation questions include:

• Can frontline workers complete the workflow in realistic field conditions?
• Does use persist after the first training wave?
• Do supervisors receive data in time to act on it?
• Does the intervention add work, remove work, or just rearrange work?
• What breaks first when the deployment expands?

Industry applications

Community health programs

For community health worker programs, the evidence bar is usually practical rather than academic. Program leaders want to know whether workers can complete tasks quickly, whether decision support is understandable, and whether referral pathways become more reliable. If a tool requires constant connectivity, frequent retraining, or hard-to-replace hardware, the evidence base needs to say that plainly.

That is why workflow evidence matters so much in LMIC settings. A ministry may be less interested in a headline outcome than in whether the intervention still works during outreach days, household visits, or rural screening campaigns.

Donor-funded implementation portfolios

USAID, UNICEF, PEPFAR, and large NGOs tend to ask a more layered set of questions. They want operational evidence, outcome evidence, and a believable path to national ownership. This is where the Digital Implementation Investment Guide, developed by WHO, UNICEF, PATH, and UNFPA, becomes relevant. It is not a study, but it reflects a serious shift in the field: evidence has to support investment and integration decisions, not just publication.

In plain terms, funders increasingly want to know whether a digital intervention fits existing architecture, budget cycles, and workforce models.

Research and policy institutions

Academic and policy audiences usually care about generalizability. They want to know whether findings from one district travel to other settings. Fair question. Still, I think people overstate how transferable most digital health evidence really is. Context matters a lot. Power reliability, procurement rules, training cadence, language support, and supervisory capacity can all change results. The best evidence base does not hide that. It documents it.

Current research and evidence

The strongest recent literature points in the same direction: evidence for digital health interventions in LMICs should be cumulative, operational, and decision-ready.

The WHO practical guide from 2016 remains a solid starting point because it separates routine monitoring from formal evaluation and pushes teams to define indicators before rollout. That sounds basic, but plenty of projects still retrofit their evaluation strategy after launch.

Proctor and colleagues at Washington University in St. Louis gave the field a durable vocabulary in 2011 by distinguishing implementation outcomes from service and clinical outcomes. That distinction matters because weak implementation can make a good intervention look ineffective.

Odoh and Aimiosior's 2024 review adds an LMIC-specific reminder. They found that digital health interventions with more strategic use of implementation science handled sociotechnical complexity better and tended to show stronger adoption and utilization. For medhealthscan.com's audience, that should land clearly: field evidence gets stronger when the rollout plan is treated as part of the intervention, not as an afterthought.

Economic evidence is still thinner than it should be. Andrea Gentili and colleagues, writing in Frontiers in Public Health in 2022, reviewed the cost-effectiveness literature on digital health interventions and found a generally favorable picture overall, but also major heterogeneity in methods and a shortage of studies from lower-income settings. That is important. Cost arguments are often where scale decisions live or die, yet the evidence base remains uneven.

There is also a taxonomy problem. Alain Labrique of the Johns Hopkins Bloomberg School of Public Health helped lead WHO's 2018 Classification of Digital Health Interventions, which tried to give the field a shared language. That may sound bureaucratic, but it solves a real issue. If programs use the same words to describe very different tools, the evidence base gets noisy fast.

A more usable evidence stack for LMIC deployments usually includes:

• Descriptive operations data from routine use, not just pilot launch windows
• Mixed-method implementation work with interviews, observations, and site comparisons
• Outcome measurement tied to service delivery or public-health goals
• Cost analysis that reflects training, maintenance, replacement, and supervision costs
• Context documentation so others know what conditions shaped the results

The future of building evidence in LMIC digital health

The field is getting a little less enchanted with pilots, which is probably healthy. Buyers and ministries are asking harder questions now. Can this integrate? Can it survive staff turnover? Can domestic budgets support it? Does it help rural programs or mostly connected urban ones?

That changes what counts as good evidence.

The next wave will likely rely more on pragmatic and embedded evaluation. Instead of waiting for a standalone study every few years, programs will combine routine data, implementation indicators, and periodic outcome checks. That approach is less glamorous than a big splashy trial, but it is often more useful for real operating decisions.

I also expect stronger pressure for evidence that travels across administrative levels. District teams need workflow evidence. National teams need budget and interoperability evidence. Funders need comparative evidence across settings. One report rarely satisfies all three, so evidence packages will need to be built with multiple audiences in mind.

For organizations working in this space, including the direction Circadify is pursuing, the practical takeaway is simple: build the evidence plan at the same time you build the deployment plan. If the intervention reaches the field before the evaluation logic is settled, the program is already behind.

Frequently Asked Questions

What does an evidence base for digital health interventions in LMICs actually include?

Usually a combination of monitoring data, implementation research, outcome evaluation, economic analysis, and equity review. One adoption chart is not an evidence base.

Why are implementation outcomes so important in LMIC settings?

Because many digital health programs succeed or fail on execution details such as training, connectivity, supervision, and workflow fit. If those are not measured, outcome data can be misleading.

Do digital health programs in LMICs always need randomized trials?

No. Randomized studies can help in some settings, but many programs also need pragmatic evaluations, mixed-method implementation studies, and routine operational data to support real scale decisions.

Why is economic evidence still a weak point?

Because costing methods vary, long-term maintenance costs are often undercounted, and many published evaluations come from upper-middle-income settings rather than the lowest-resource contexts.

A serious evidence base is less about proving that digital health sounds promising and more about showing where it works, for whom, at what cost, and under what conditions. For related reading, see our analysis of how to measure the impact of digital health interventions and how mHealth evidence influences health policy in Africa. Circadify's broader global health coverage is here: circadify.com/blog.